drugset / Trial / NCT02927223
Atropine in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
NaSingle-groupOpen-labelOther
Summary
To test the hypothesis that increasing the sinus node rate with atropine treatment prior to exercise will reduce exercise-triggered ventricular ectopy compared to baseline in patients with CPVT.
Timeline
- Start
- 2016-10
- Primary completion
- 2019-02
- Completion
- 2019-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atropine | Other / unclassified | 0.04 mg/kg | Intravenous |